BEGIN:VCALENDAR
VERSION:2.0
METHOD:PUBLISH
CALSCALE:GREGORIAN
PRODID:-//WordPress - MECv7.26.0//EN
X-ORIGINAL-URL:https://steven-kantor.com/
X-WR-CALNAME:Steven A Kantor
X-WR-CALDESC:
X-WR-TIMEZONE:America/New_York
BEGIN:VTIMEZONE
TZID:America/New_York
X-LIC-LOCATION:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20260308T030000
RRULE:FREQ=YEARLY;BYMONTH=03;BYDAY=2SU
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20261101T010000
RRULE:FREQ=YEARLY;BYMONTH=11;BYDAY=1SU
END:STANDARD
END:VTIMEZONE
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-PUBLISHED-TTL:PT1H
X-MS-OLK-FORCEINSPECTOROPEN:TRUE
BEGIN:VEVENT
CLASS:PUBLIC
UID:MEC-08048a9c5630ccb67789a198f35d30ec@steven-kantor.com
DTSTART;TZID=America/New_York:20260402T080000
DTEND;TZID=America/New_York:20260402T180000
DTSTAMP:20260402T083053Z
CREATED:20260402
LAST-MODIFIED:20260501
PRIORITY:5
SEQUENCE:3
TRANSP:OPAQUE
SUMMARY:Life Sciences Collaborative – Boston Meeting Highlights Regenerative Medicine and Biomanufacturing Innovation
DESCRIPTION:The Life Sciences Collaborative – Boston Chapter (LSC Boston) held its March 31 meeting at Riverside Partners, bringing together leaders from across the life sciences ecosystem for a discussion focused on innovation, advanced manufacturing, and the future of healthcare.\nThe session featured Ned Gordon, Chief Commercial Officer of the Advanced Regenerative Manufacturing Institute (ARMI), who led an insightful conversation on the rapidly evolving fields of regenerative medicine and biomanufacturing.\nAdvancing Regenerative Medicine Through Scalable Manufacturing\nDuring the discussion, Gordon highlighted the critical role organizations like ARMI play in bridging the gap between research and commercialization. As new therapies emerge—particularly in cell and gene therapy—the ability to scale manufacturing efficiently and reliably has become a central challenge for the industry.\nThe conversation emphasized that innovation alone is not enough. Success in regenerative medicine requires the development of robust manufacturing infrastructure, standardized processes, and scalable production capabilities to bring therapies from the lab to patients.\nThe Importance of Collaboration Across the Ecosystem\nA key theme of the meeting was the importance of collaboration across industry, academia, and government. Participants discussed how partnerships among these sectors are essential to accelerating innovation, supporting workforce development, and addressing commercialization challenges.\nThe need for coordinated efforts to build talent pipelines and develop specialized skills in biomanufacturing was also highlighted as a priority for sustaining growth in the life sciences sector.\nStrengthening the Boston Life Sciences Community\nThe meeting reinforced the strength of the Boston life sciences ecosystem, one of the leading hubs for biotechnology and healthcare innovation. By bringing together experienced professionals to share insights and perspectives, the Life Sciences Collaborative continues to provide a valuable forum for dialogue and relationship-building.\nThe group extends its appreciation to Ned Gordon for sharing his expertise and to Riverside Partners for hosting the event.\n
URL:https://steven-kantor.com/events/life-sciences-collaborative-boston-meeting-highlights-regenerative-medicine-and-biomanufacturing-innovation/
CATEGORIES:LSC - Boston
ATTACH;FMTTYPE=image/png:https://steven-kantor.com/wp-content/uploads/2026/04/Screenshot-2026-04-02-at-9.03.30-AM-e1775517262864.png
END:VEVENT
END:VCALENDAR